Correction: Active Biotech Year End Report 2021 : vimarsana.

The correction refers to the administrative costs for the period January - December 2021 that due to oversight have been stated too low. The incorrect amount was SEK 14,0 M, the correct amount is SEK 15

Related Keywords

Stockholm , Sweden , Hans Kolam , Erik Vahtola , Loncode Institute , Nasdaq , Annual Report , Active Biotech , Chief Medical Officer , End Report , Correction , Ctive , Biotech , Ear , Report , 021 ,